FATE
Fate Therapeutics, Inc. · Healthcare
General Counsel and Secretary Cindy Tahl sold $3.0M of Fate Therapeutics, Inc.
Sold$2,966,853
$59.34Price
50,000Shares
−23%Stake
What FATE did after the filing
- The stock from Wed, Jan 5 open, $55.26
- −39.0%
- S&P 500, same days
- −8.4%
Measured over 30 trading days, to the Feb 17 close.
Traded Mon, Jan 3. Filed Tue, Jan 4, 4:03 PM ET, after the close. Returns use the Jan 5 open and the Feb 17 close. Not investment advice.